BOM/533573 (BOM/533573)

Bombay Stock Exchange: BOM/533573 · INR

₹783

+12.30 (+1.6%)· Recorded snapshot

Market cap	153.9B
Revenue (ttm)	77.8B
Net income (ttm)	6.9B
EPS (ttm)	₹35.3
P/E (trailing)	22.2x
P/E (forward)	19.4x
Dividend	₹12.0 (1.53%)
Volume	3,412

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 77.8B
Net income (ttm): 6.9B
EPS (ttm): ₹35.3
P/E (trailing): 22.2x
P/E (forward): 19.4x
Market cap: 153.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.4

P25 n/aP50 n/aP75 n/a

Trailing P/E22.2

P25 n/aP50 n/aP75 n/a

ROE12.4

P25 n/aP50 n/aP75 n/a

ROIC11.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/533573 indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

INR

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-06
Employees	17,244
Employees change	673
Employees growth	4.06%
Enterprise value	INR 166.1B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1907
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE901L01018
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Market cap	INR 153.9B
Next earnings date	2026-11-06
Price	INR 783.25
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/533573
Website	https://alembicpharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	20.46x
Average P/E ratio (10Y)	25.36x
Average P/E ratio (3Y)	28.88x
Average P/E ratio (5Y)	30.43x
Earnings yield	4.5%
EV/Earnings	23.96x
EV/EBIT	20.15x
EV/EBITDA	14.4x
EV/FCF	47.73x
EV/Sales	2.13x
FCF / EV yield	2.1%
FCF yield	2.26%
Forward P/E	19.44x
Graham number	471.22441
Graham upside	-38.88%
Industry forward P/E	33.04x
Industry P/E	38.96x
Lynch fair value	INR 173.73
Lynch upside	-77.47%
P/B ratio	2.71x
P/E ratio	22.2x
P/FCF ratio	44.2x
P/OCF ratio	19.66x
P/S ratio	1.98x
Price / tangible book value	2.86x
Price/EBITDA ratio	13.56x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.58%
EBITDA margin	14.58%
Effective tax rate	4.98%
FCF margin	4.74%
Gross margin	70.56%
Operating margin	10.58%
Pretax margin	9.32%
Profit margin	8.91%
Profit per employee	INR 402,146
Profitable quarters	16
Profitable years	17
Revenue per employee	INR 4.5M
ROA	6.03%
ROA (5Y)	5.68%
ROCE	12.92%
ROE	12.36%
ROE (5Y)	10.92%
ROIC	11.34%
ROIC (5Y)	10.2%
Tax / revenue	0.46%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	14.94%
EPS growth (Q)	12.1%
EPS growth (QoQ)	-14.65%
EPS growth 10Y	-1.23%
EPS growth 3Y	9.47%
EPS growth 5Y	-7.88%
EPS growth quarters	2
EPS growth years	1
FCF growth 3Y	7.46%
FCF growth 5Y	-15.41%
Gross profit growth	11.47%
Gross profit growth (Q)	17.37%
Gross profit growth 3Y	10.54%
Gross profit growth 5Y	6.6%
Net income growth	14.98%
Net income growth (Q)	12.11%
Net income growth (QoQ)	-14.62%
Net income growth 3Y	9.48%
Net income growth 5Y	-7.81%
Net income growth quarters	2
Net income growth years	1
OCF growth	789.77%
OCF growth 10Y	-1.89%
OCF growth 3Y	2.64%
OCF growth 5Y	-11.76%
Operating income growth	7.02%
Operating income growth (Q)	12.8%
Operating income growth 3Y	9.77%
Operating income growth 5Y	-5.86%
Revenue growth	14.12%
Revenue growth (Q)	25.67%
Revenue growth (QoQ)	16.35%
Revenue growth 10Y	8.98%
Revenue growth 3Y	9.82%
Revenue growth 5Y	7.68%
Revenue growth quarters	13
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -4.3B
Depreciation and amortization	INR 3.1B
EBIT	INR 8.2B
EBITDA	INR 11.3B
EPS	INR 35.28
Financing cash flow	INR -1.6B
Free cash flow	INR 3.5B
Gross profit	INR 54.9B
Income taxes	INR 361.4M
Investing cash flow	INR -5.1B
Net borrowing	INR 1.4B
Net cash flow	INR 1.1B
Net income	INR 6.9B
Operating income	INR 8.2B
Revenue	INR 77.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 288.70
Debt / EBITDA	1.24
Debt / equity	0.25
Debt / FCF	4.11
Interest coverage	8.43
Net cash (debt)	INR -12.3B
Net cash / market cap	-8.02%
Net debt / EBITDA	1.09
Net debt / equity	0.22
Net debt / FCF	3.54
Piotroski F-Score	5
Shareholders' equity	INR 56.7B
Tangible book value	INR 53.9B
Tangible book value per share	INR 274.11
Total cash	INR 2B
Total debt	INR 14.3B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.89
Current ratio	1.76
Inventory turnover	0.87
Quick ratio	0.65
Working capital	INR 19.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.04%
Dividend growth	9.09%
Dividend growth (10Y)	11.61%
Dividend growth (3Y)	14.47%
Dividend growth (5Y)	-3.04%
Dividend growth years	0
Dividend payment date	2026-09-04
Dividend payment years	15
Dividend payout frequency	Annual
Dividend per share	INR 12.00
Dividend yield	1.53%
Ex-dividend date	2026-07-29
Last dividend	INR 12.00
Payout ratio	34.01%
Shareholder yield	1.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	16.55%
10Y return CAGR	2.78%
10Y total return	31.59%
150-day SMA	INR 783.34
15Y price change	1,592.54%
15Y return CAGR	22.23%
15Y total return	1,930.83%
1D price change	1.6%
1M price change	-10.73%
1M total return	-10.73%
1W price change	-2.18%
1W total return	-2.18%
1Y price change	-16.54%
1Y return CAGR	-15.3%
1Y total return	-15.29%
20-day SMA	INR 803.40
200-day SMA	INR 778.01
3M price change	-3.21%
3M total return	-1.77%
3Y price change	3.22%
3Y return CAGR	2.32%
3Y total return	7.11%
50-day SMA	INR 816.42
50-day SMA vs 200-day SMA	50over200
52-week high	INR 998.00
52-week high date	2025-11-04
52-week low	INR 635.30
52-week low date	2026-03-23
5Y price change	1.94%
5Y return CAGR	1.66%
5Y total return	8.6%
6M price change	2.64%
6M total return	4.17%
All-time high	INR 1,296.15
All-time high date	2024-10-09
All-time low	INR 34.00
All-time low date	2012-01-02
Average true range (ATR)	INR 21.51
Average volume	7.7K
Change from 52-week high	-21.52%
Change from 52-week low	23.29%
Change from all-time high	-40.52%
Change from all-time low	2,167.5%
Change from open	1.71%
Day's gap	-0.12%
Dollar volume	INR 2.7M
High price	INR 785.90
Low price	INR 769.50
Monthly RSI	45.37
Open price	INR 770.05
Position in 52-week range	83.84%
Previous close	INR 770.95
Price vs 150-day SMA	-1.58%
Price vs 20-day SMA	-4.04%
Price vs 200-day SMA	-0.91%
Price vs 50-day SMA	-5.57%
Relative volume	0.44
RSI	36.28
Sharpe ratio	-0.68
Sharpe ratio (3Y)	0.1
Sharpe ratio (5Y)	0.05
Sortino ratio	-0.74
Sortino ratio (3Y)	0.34
Sortino ratio (5Y)	0.28
Volume	3.4K
Weekly RSI	44.55
YTD price change	-9.11%
YTD total return	-7.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	57.6M
Shares change (QoQ)	0.03%
Shares change (YoY)	0.04%
Shares held by insiders	5.53%
Shares held by institutions	16.62%

Deeper analysis on BOM/533573

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/533573 report

Is a complete BOM/533573 research report available?

No complete published report is available for bom/533573 (BOM/533573) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/533573 (BOM/533573)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/533573

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/533573 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/533573

Frequently asked questions